4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-067072
CHIEF FINANCIAL OFFICER bought 5,000 shares at $0.90 ($4,500)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| King Michael CHIEF FINANCIAL OFFICER | 2023-11-30 | Purchase | +5,000 | $0.90 | $4,500 | 5,000 | D |
| Open-market purchases · 5,000 sh · avg $0.90 · $4,500 | |||||||
Loading xslF345X05/ownership.xml…